BG
TBRA

BlackRock Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

BlackRock Group’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-9,879
Closed -$604K – 2917
2014
Q2 		$604K Buy
9,879
+7,918
+404% +$482K ﹤0.01% 2119
2014
Q1 		$221K Buy
+1,961
New +$138K ﹤0.01% 2452

Other funds holding TBRA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Group's TBRA Position: Q3 2014 in Review

BlackRock Group sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2014, closing a stake of 9,879 shares — an estimated $604K sold.

BlackRock Group first reported a position in TBRA in Q1 2014 and held it in 2 quarters. The position peaked at $604K in Q2 2014. 47 funds tracked by Wall St. Rank hold TBRA as of Q3 2014.

  • BlackRock Group reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • BlackRock Group sold 9,879 Tobira Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $604K.
  • BlackRock Group first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 2 quarters.
  • BlackRock Group's Tobira Therapeutics, Inc. Common Stock position peaked at $604K in Q2 2014.
  • 47 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2014.

Based on BlackRock Group's 13F filing for Q3 2014, filed 29 Oct 2014.